Status:
COMPLETED
Hyperbaric Oxygen Therapy Effects on Pulmonary Functions
Lead Sponsor:
Assaf-Harofeh Medical Center
Conditions:
Oxygen Toxicity
Hyperoxia
Brief Summary
Prospective analysis included patients, 18 years or older, scheduled for 60 daily HBOT sessions between 2016-2018. Each session was 90 min of 100% oxygen at 2 ATA with 5 minutes air breaks every 20 mi...
Detailed Description
After signing an informed consent form, the participants underwent a pulmonary function baseline evaluation. Participants were treated in a multiplace chamber (HAUX-Life-Support GmbH) for 60 daily ses...
Eligibility Criteria
Inclusion
- 18 and older patients
- scheduled for 60 HBOT sessions for any indication
Exclusion
- Active smokers were excluded but patients who quit smoking more than six months prior to inclusion were allowed in the study.
- active smoking
- severe known pulmonary disease
- chest pathology incompatible with HBOT
- inner ear disease
- claustrophobia
- other neurological conditions
- pregnancy
- previous HBOT within six months prior to inclusion
- the inability to sign informed consent.
Key Trial Info
Start Date :
January 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2018
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT03754985
Start Date
January 1 2016
End Date
October 1 2018
Last Update
November 27 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Amir Hadanny
Ẕerifin, Israel